WO2013065923A1 - 조직거상용 이식물 - Google Patents
조직거상용 이식물 Download PDFInfo
- Publication number
- WO2013065923A1 WO2013065923A1 PCT/KR2012/004421 KR2012004421W WO2013065923A1 WO 2013065923 A1 WO2013065923 A1 WO 2013065923A1 KR 2012004421 W KR2012004421 W KR 2012004421W WO 2013065923 A1 WO2013065923 A1 WO 2013065923A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tissue
- mesh member
- living body
- thread
- implant
- Prior art date
Links
- 210000001519 tissue Anatomy 0.000 claims abstract description 165
- 210000003205 muscle Anatomy 0.000 claims abstract description 26
- 238000007920 subcutaneous administration Methods 0.000 claims abstract description 23
- 238000003780 insertion Methods 0.000 claims description 92
- 230000037431 insertion Effects 0.000 claims description 89
- 239000007943 implant Substances 0.000 claims description 80
- 238000000034 method Methods 0.000 claims description 50
- 238000007665 sagging Methods 0.000 claims description 19
- 239000011800 void material Substances 0.000 claims description 9
- 239000000853 adhesive Substances 0.000 claims description 7
- 230000001070 adhesive effect Effects 0.000 claims description 7
- 238000005520 cutting process Methods 0.000 claims description 7
- 238000001746 injection moulding Methods 0.000 claims description 7
- 210000003195 fascia Anatomy 0.000 claims description 5
- 239000004743 Polypropylene Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 229920001610 polycaprolactone Polymers 0.000 claims description 4
- 239000002861 polymer material Substances 0.000 claims description 4
- -1 polypropylene Polymers 0.000 claims description 4
- 229920001155 polypropylene Polymers 0.000 claims description 4
- 229920000954 Polyglycolide Polymers 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 claims description 3
- 239000004632 polycaprolactone Substances 0.000 claims description 3
- 239000000622 polydioxanone Substances 0.000 claims description 3
- 239000004633 polyglycolic acid Substances 0.000 claims description 3
- 238000001727 in vivo Methods 0.000 claims description 2
- 238000009940 knitting Methods 0.000 claims description 2
- 230000000149 penetrating effect Effects 0.000 claims description 2
- 229920001432 poly(L-lactide) Polymers 0.000 claims description 2
- 230000015271 coagulation Effects 0.000 claims 3
- 238000005345 coagulation Methods 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 238000003892 spreading Methods 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 13
- 239000011148 porous material Substances 0.000 description 10
- 238000002513 implantation Methods 0.000 description 9
- 230000001815 facial effect Effects 0.000 description 8
- 230000037303 wrinkles Effects 0.000 description 8
- 206010033675 panniculitis Diseases 0.000 description 5
- 210000004304 subcutaneous tissue Anatomy 0.000 description 5
- 239000000463 material Substances 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 239000000560 biocompatible material Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 206010019909 Hernia Diseases 0.000 description 2
- 206010046543 Urinary incontinence Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 210000001097 facial muscle Anatomy 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000003028 elevating effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
- A61B17/06166—Sutures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
- A45D44/00—Other cosmetic or toiletry articles, e.g. for hairdressers' rooms
- A45D44/22—Face shaping devices, e.g. chin straps; Wrinkle removers, e.g. stretching the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0059—Cosmetic or alloplastic implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/10—Hair or skin implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00792—Plastic surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
- A61B17/06166—Sutures
- A61B2017/06176—Sutures with protrusions, e.g. barbs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0051—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in tissue ingrowth capacity, e.g. made from both ingrowth-promoting and ingrowth-preventing parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
Definitions
- the present invention relates to a tissue-coated implant, and more particularly, by combining or integrating a mesh member having a plurality of pores on the distal side of the thread for inserting a living body to sag or wrinkle the skin with one tissue-coated implant.
- the present invention relates to an implantable tissue implant that can be easily deployed.
- the face or neck of the body part is the skin elasticity is degraded by aging and stress, and the skin and subcutaneous tissue sagging and wrinkles occur over a specific area or the entire face and neck.
- Facial elevation one of the operations that pulls wrinkles on the skin or subcutaneous tissues of the face or neck, is performed by using classic facial elevation techniques, such as invasive facial elevations and special chambers, which relieve and lift up the sagging tissues through a noticeable incision.
- classic facial elevation techniques such as invasive facial elevations and special chambers, which relieve and lift up the sagging tissues through a noticeable incision.
- non-invasive facial lifting technique that is simply performed.
- Korean Patent Publication No. 2010-0134941 Korean Patent Publication No. 2007-0093256, Korean Patent Publication No. 2007-0048178, Korean Patent Publication No. 2010-0058650, Korean Patent Registration No. 10-0724706, Korea Implants, such as implants formed of a mesh form or a porous material, seals for living body insertion with micropores or protrusions, and the like, registered patent No. 10-0886757, Korean Utility Model No. 20-0442490, and International Publication No. WO 2005/096956; An insertion member or the like for treating an implant is disclosed.
- Thread lifting using a medical thread is a method of forming a fine cog or barb on a synthetic yarn and pulling the medical thread in a state where the medical thread is inserted into the skin.
- the yarn is pulled in a non-uniform manner, and in addition to the disadvantage of lowering the effect of lifting the tissue, the cog is damaged or the thread is pulled out.
- the protrusion does not naturally pull to the tissue around the treatment site, and thus pulls only one point of the tissue, thereby degrading adhesion to the tissue and tearing the tissue, such as tearing the tissue.
- the existing thread used in the tissue coarse using the thread can be loosened after the procedure by slipping in the tissue, and because of the weak fixation force to fix the skin tissue at the site, when the muscle is moved, the adhesion with the tissue is lost. To reduce within a short time, or if a lot of tension is applied after the procedure there is a problem that the projection is damaged and the effect of pulling down the tissue is inferior.
- tissue elevation using only a band-shaped mesh is a procedure that requires incision and secondary surgery, the procedure is complex and difficult to remove after the procedure as a whole has a disadvantage in that it is inconvenient for the patient is limited.
- the cohesion using only a band-shaped mesh has problems such as tissue damage during the procedure.
- meshes used for hernias and urinary incontinence should be tension-free and minimize adhesion to organs.However, in face elevations, it is necessary to pull up sagging tissues as the aging progresses and to counter muscle movements and trauma. There is a problem in that it is difficult to use the mesh used for hernia or urinary incontinence as it is, because there is a contradictory problem such as maintaining tension and adhesion to the tissue.
- the present invention was created in order to solve the above-mentioned problems, and more specifically, the mesh member of the biocompatible material is combined or integrated on the distal side of the thread for inserting the living body, thereby sagging or wrinkled skin with one tissue-coated implant.
- An object of the present invention is to provide an implantable tissue implant that can be easily deployed.
- the present invention is another object to easily and firmly elevating tissue by producing a graft for implantation by combining or unifying the mesh member of the form and the seal for bio-insertion.
- the present invention is to be adhered to the mesh member located on the distal side as the tissue of the treatment area grows, so that the pulling force to pull the sag tissue of the distal part, that is, the immediate area immediately above the wrinkles, which is required to pull, the re-phenomena of sag There is another purpose to minimize this.
- the present invention is to be adhered to the mesh member to the surrounding tissue, so that the pulling of the tissue is naturally formed, and even if the tension applied to the thread for inserting the living body increases the damage of the projections to minimize the damage of the projections and tissues around the projections
- Another object is to increase the fixing force of the tissues adhered to the mesh member to enable efficient tissue elevation.
- the present invention is the mesh member of the implant is a mesh-shaped graft material consisting of a ring shape has an appropriate elongation and maintains a constant tension, it is easy to restore the circular shape after transplantation and facial muscles of the human body by tissue ingrowth It is possible to move together naturally according to the movement of the back and has another purpose to minimize the feeling of soft foreign matter.
- the present invention by using the implant to combine or integrated the living body insertion thread and the mesh member on the tissue elevation, to minimize the discomfort of the patient during the procedure, if inevitable need to remove, compared to the tissue elevation using the existing yarn
- Another object is that the mesh member located in the distal portion is easily caught by the removal tool for easy removal.
- the present invention has another object to prevent side effects after the procedure and to minimize the sense of foreign body by using a biocompatible material harmless to the human body.
- the present invention since the structure of the mesh member can be produced in a variety of forms, the adhesion of the tissue and the mesh member of the treatment site can be improved to the desired degree, by being coupled to the thread for living body insertion without being limited by the number of mesh members Another purpose is that it can be used to maximize the effect of the procedure.
- the present invention by inserting the mesh member coupled to the thread for the insertion of the living body between the sagging or wrinkled skin and the subcutaneous muscle layer in the other parts other than the facial area, thereby improving adhesion to the tissue, pulling the sagging or wrinkled skin and subcutaneous tissue Another purpose is to make it easy to unfold and unfold.
- the present invention unlike the usual cutting type projections can be produced in the number and size of the mesh member itself and the adhesion force due to the growth in the tissue after transplantation and the projection does not significantly reduce the tensile force of the yarn compared to the existing yarn
- Another object is to overcome the problem of reducing the tensile force of the yarn.
- the present invention in addition to the role of the projection to support the initial fixing force of the projection attached to the implant to prevent the movement of the mesh member, and another object to distribute the tension applied to the mesh member .
- tissue-elevating implant of the present invention for achieving the above object, in the tissue-elevating implant that can be inserted between the sagging or wrinkled skin (S) and the subcutaneous muscle (m) layer to pull or unfold the tissue ,
- the tissue graft implant (2), the living body insertion thread (6) which can be inserted between the skin and the subcutaneous muscle layer and has a distal portion and a proximal portion to be pulled;
- a mesh member 4 fixedly coupled to the distal side of the seal for inserting the living body 6, in which a plurality of voids are provided, and in which the living tissue is grown and filled.
- tissue-elevating implant of the present invention for achieving the above object, in the tissue-elevating implant that can be inserted between the sagging or wrinkled skin (S) and the subcutaneous muscle (m) layer to pull or unfold the tissue ,
- the tissue graft implant (2), the living body insertion thread (6) which can be inserted between the skin and the subcutaneous muscle layer and has a distal portion and a proximal portion to be pulled;
- a mesh which is integrally formed with the body inserting thread 6 on a distal side of the body inserting thread 6 and is formed in one body, and a plurality of pores are provided and biological tissue is grown and filled in the pores.
- a member 4 which is integrally formed with the body inserting thread 6 on a distal side of the body inserting thread 6 and is formed in one body, and a plurality of pores are provided and biological tissue is grown and filled in the pores.
- the protrusion 8 may be formed in the seal 6 for inserting the tissue.
- the tissue giant implant, the mesh member may be formed in a cylindrical or planar shape.
- the tissue graft implant, the living body insertion thread 6 can penetrate the mesh member 4 while extending a predetermined length to both sides of the mesh member (4).
- both ends of the mesh member may be fixedly coupled to the seal for inserting the living body.
- the bio-insertable seal 6 and the mesh member 4 may be combined by any one of a method of heat bonding, knotting or attaching with a medical adhesive. have.
- the living body insertion thread 6 and the mesh member 4 may be integrated through injection molding.
- the seal for inserting the living body 6 may have a thickness of 0.25 mm to 1.5 mm to ensure the stability of the procedure so that no indication of the procedure appears on the outside.
- the seal for living body 6 is a projection (t) protruding to the surface in a direction in which the projections (8) and the fascia by connecting integrally with the projection and omitting the projections It may include a protrusion (r) is formed to be fixed to.
- the protrusion (t), 15mm ⁇ is a length that can be pulled through the skin (S) through the skin S during the lifting adjustment to one side to which the mesh member 4 is coupled and can be easily removed after fixing.
- the removal part a may be formed within 25 mm.
- the projections 8 of the projections t have a spacing of 2 to 4 mm for each projection, and a cut depth of 25% or less in the case of a cutting projection, and a cutting angle. Can be in the range of 10 dB or less.
- the projection 8 of the protrusion t may be formed in a spiral shape on the surface of the bio-insertable seal 6 so as to disperse the supporting force.
- the mesh member 4 may be knitted or injection molded.
- the mesh member 4 may be formed by heat treatment to maintain the tensile force.
- the mesh member may be coupled 15 mm to 25 mm rearward from the distal end of the removal portion (a) of the seal for inserting the living body 6 to enable pulling adjustment of the mesh member.
- the length is 15mm ⁇ 60mm
- the outer diameter is 3.0mm ⁇ 4.5mm
- the mesh void (h) is 1mm ⁇ 2mm in size so that adhesion and support of the tissue is improved Can be.
- the length is 15mm ⁇ 60mm
- the width is 3.0mm ⁇ 4.5mm
- the mesh void (h) may be 1mm ⁇ 2mm in size.
- the tissue-coated implant is harmless to the human body and is absorbed in vivo over time by polydioxanone, polyl-lactic acid, polyglycolic acid, Polycaprolactone (polycaprolactone) and copolymers thereof may be formed of a biocompatible medical polymer material or a biocompatible medical polymer material made of polypropylene (polyprophylene) and mixtures thereof.
- the tissue graft 2 has a planar mesh member 4 formed in a planar shape with a predetermined width, and a gap h of the planar mesh member 4 from the upper part of the living body insertion chamber 6.
- the living body insertion thread 6 is formed with a length of 120 mm to 230 mm to expose a part of the thread 6 inserted into the insertion tube 20 h and the insertion tube 20 h.
- a guide portion (g) extending without protrusions may be formed on one side of the seal 6 to guide the passage of the seal 6 inserted therein.
- the tissue giant implant (2), the insertion pipe (20h) is formed so as to be inserted into the tissue is 140mm ⁇ 250mm length, the outer diameter is 1.6mm ⁇ 2.8mm and the inner diameter is 1.3mm ⁇ 2.5mm, and the insertion tube
- the guide g of the thread 6 can be hooked through the formed hole, and can be treated using a thread guide needle passing through the insertion tube 20h.
- the tissue graft of the present invention has an effect of improving adhesion to the tissue and surrounding tissue of the procedure by combining the mesh member of a predetermined shape with the thread for bio-insertion and performing the procedure in the subcutaneous tissue.
- tissue elevation implant of the present invention by providing a tissue elevation implant in which a certain type of mesh member is coupled to the living body insertion thread, it is effective to facilitate wrinkle removal and lifting of sagging tissues have.
- the tissue graft of the present invention the sagging tissue and the surrounding tissue is naturally lifted at the same time, thereby preventing the side effects such as dimples (dimple) of the treatment site to enable a procedure that satisfies both patients and doctors It works.
- the tissue elevation implant of the present invention has the effect of significantly reducing the recurrence of the sag due to the increase in the fixing force by the adhesion of the mesh member and the tissue in the distal portion.
- the graft implant for tissue of the present invention as the mesh member is made of a biocompatible material without a human body rejection reaction, such as polypropylene, there is no side effect there is an effect that can be used semi-permanently.
- the edge portion of the mesh member is formed in a loop shape or other smooth curve, has a light and moderate stretch, and the tissue ingrowth into the mesh pores after implantation (tissue ingrowth) By inducing), it naturally harmonizes with the movement of facial muscles to minimize foreign body feelings and improve patient satisfaction.
- tissue-elevating implant of the present invention has the effect of reducing the risk of infection because the mesh member is monofilament and all the pores maintain a sufficient size to pass macrophage and neutrophils. have.
- the tissue implant graft of the present invention is a living body insertion thread is responsible for most of the tension
- the living body thread passing through the mesh member has a form coupled to the body and the mesh member while the load bear the tension
- the mesh member is heat-treated to maintain the proper tensile force
- the mesh member can be relatively small in size compared to the existing implant, and the mesh member can be rolled or folded even when the tension is changed. Deformation such as string formation is minimized, thereby maintaining the function of the desired mesh member.
- the living body insertion thread is responsible for most of the tension while passing through the mesh member, the mesh void deformation is minimized, as well as the light weight of the material of the mesh member (light weight) implantation
- the pore can be used to maintain the material at least about 1mm in size can reduce the foreign body feeling by minimizing the fiber bridging, or shrinkage of the mesh member thereby.
- the tissue-coated implant of the present invention the proper adhesion between the mesh member and the sagging tissue located in the distal portion after transplantation proceeds, by preventing the recurrence of the distal sag and the recurrence of the wrinkles difficult to resolve in conventional surgery There is an effect to improve the effect and significantly reduce the complaints of patients after the procedure.
- tissue graft is used to pull the surrounding tissue adhered to the mesh member by using the mesh member, it is possible to maintain the natural and stable pulling of the tissue as compared to the thread lifting that is pulled only by the bio-insertion thread. There is.
- FIG. 1 is a view showing a graft for implantation according to an embodiment of the present invention
- Figure 2 is a partially enlarged view of Figure 1
- Figure 3 is a sectional view III-III of Figure 2
- Figure 4 is Figure 2 IV-IV section of the.
- FIG. 5 is a view showing a graft for implantation according to another embodiment of the present invention
- Figure 6 is a partially enlarged view of FIG.
- FIG. 7 is a view showing a graft implant according to another embodiment of the present invention.
- FIG. 8 is a view showing a graft for implantation according to another embodiment of the present invention.
- FIG. 9 is a view showing a graft implant according to another embodiment of the present invention.
- FIG. 10 is a view showing a graft for implantation according to another embodiment of the present invention
- Figure 11 is a XI-XI cross-sectional view of FIG.
- Figure 12 is a cross-sectional view of a tissue elevation implant according to another embodiment of the present invention.
- FIG. 13 is a view showing a graft for implantation according to another embodiment of the present invention
- FIG. 14 is a cross-sectional view taken along line XIV-XIV of FIG. 13.
- Figure 15 is an enlarged view showing a state in which the tissue graft according to the present invention is installed in the skin and subcutaneous muscle layer.
- Figure 16 is a view showing the insertion member for the procedure for implantation of tissue graft of the present invention
- Figure 17 is a cross-sectional view of Figure 16 combined.
- FIG. 18 is a view showing a state in which the tissue graft according to the invention is inserted into the insertion member.
- FIG. 19 is a view showing an example in which the tissue elevation implant according to the present invention is performed in the skin and subcutaneous muscle layer by an insertion member.
- tissue graft according to the present invention is suspended in the temporal fascia of the face and treated for facial elevation.
- Figure 21 is a view showing a thread guide needle for guiding the implant for tissue elevation of the present invention.
- Tissue giant implant 2 is inserted between the sagging or wrinkled skin (S) and the subcutaneous muscle (m) layer to pull or unfold the tissue.
- the tissue graft implant 2 is combined with the living body insertion chamber 6 in which the projections 8 are formed on the surface, and the living body insertion chamber 6.
- a mesh member 4 fixed at both ends by a living body inserting thread 6 drawn out to have an extra length on both sides.
- the seal for inserting the living body 6 may be inserted between the skin and the subcutaneous muscle layer and is a distal portion (area installed on the wrinkled skin side), which is a region where pulling is required, and a proximal portion (endless portion (r), which is a pulling portion). Side).
- the distal portion refers to a portion installed on the sagging or wrinkled skin side
- the proximal portion refers to a portion pulling the distal portion.
- the seal for inserting the living body 6 is formed with a thickness of 0.25mm ⁇ 1.5mm to ensure the stability of the procedure so that the indication of the procedure does not appear on the outside and the projections (8) protruding from the surface toward a predetermined direction ( t) and a projection-free portion r which is disposed on the other side of the projection t and can be fixed to the fascia by omitting the projection 8.
- the protruding portion (t) can be pulled through the skin (S) when the lifting control on the side coupled to the mesh member (4) and can be easily removed when the mesh member (4) is seated or fixed to the required part
- the removal part a of 15 mm-25 mm in length is formed.
- one side of the living body insertion thread (6) is 120mm ⁇ 230mm in length so that a portion of the thread inserted into the insertion tube and the living body insertion thread (6) to guide the passage of the thread inserted into the insertion tube Guide portion (g) extending from the removal portion (a) of the is provided.
- the living body insertion thread 6 is configured to penetrate the mesh member 4 while extending a predetermined length to both sides of the mesh member 4.
- the protrusion 8 may share the role of tissue coarseness with the mesh member 4 or serve as an auxiliary function, unlike the conventional thread for inserting a living body, so that the protrusion 8 may be partially depending on the treatment condition. It is also possible to have only or not, and even when the projection 8 is present, the size of the projection 8 can be reduced or the number of the projections 8 can be reduced. On the other hand, the projections 8 may also be arranged in a spiral along the longitudinal direction of the seal for inserting the living body 6 so as to easily disperse the supporting force.
- the projection 8 of the projection t has a distance of 2 to 4 mm in the interval of each projection 8, and in the case of a cutting projection, the depth of cut is 25% or less with respect to the thread for biological insertion. It is preferable to make an angle into the range of 10 degrees or less.
- the mesh member 4 is fixedly coupled to the distal side of the seal for inserting the living body 6, a plurality of voids h are provided, and living tissue is grown and filled in the voids h. .
- the mesh member 4 may have a shape in which one side and the other side are formed in a substantially triangular shape, and a plurality of ellipses are attached to each other.
- the mesh member 4 is harmless to the human body, and polydioxanone, poly- (l-lactic) acid, polyglycolic acid, It is preferable to use a bioabsorbable medical polymer material or polypropylene (polyprophylene) and a mixture thereof, which is a polycaprolactone and a copolymer thereof.
- the mesh member 4 is a planar shape, it may be knitted or formed by injection molding, it is also preferable that the heat treatment to maintain the tensile force.
- the mesh member 4 may be applied to one of the face, neck, chest, and buttocks, and may enlarge or reduce the size of the mesh according to the size of the treatment site. In addition, the number of meshes need not be one, and a mesh can be added as needed.
- the mesh member 4 is installed behind the removal portion (a) having a length of 15mm ⁇ 20mm. That is, it may be coupled 15 to 25 mm from the front end of the removal portion (a) of the seal for inserting the living body 6 to facilitate the pulling adjustment of the mesh member (4).
- the mesh member 4 has a length of 15 mm to 60 mm, a width of 3.0 mm to 4.5 mm, and a mesh void h may have a size of 1 mm to 2 mm.
- both sides of the mesh member 4 may be formed in a smooth round shape.
- both sides of the mesh member 4 are made in a round shape, damage in the skin can be minimized.
- both end sides of the mesh member 4 is the upper portion of the mesh cavity (h) as shown in Figure 3, the living body insertion thread 6 After alternately arranged in the form of a zigzag to be alternately fitted in the lower portion and the mesh member 4 and the thread for insertion of the living body 6 can be combined by heat adhesive or medical adhesive (5).
- the central region between both ends of the mesh member 4 is heat-bonded or adhesive 5 or the like in a state where the living body insertion seal 6 is placed on one side of the mesh member 4 as shown in FIG. 4. Can be combined with each other.
- the reason why the coupling method is different at both ends of the mesh member 4 and the area therebetween is that both ends of the mesh member 4 receive more force than the central area and thus require a lot of fixing force.
- the tissue graft 2 is generally similar to the configuration described in Example 1, but the rhombus shapes overlap each other to have a shape extending in one direction.
- both ends of the mesh member 4 of the tissue graft 2 disclosed in FIG. 5 are zigzag-shaped, and the bioinsertion thread 6 is coupled, and a central portion between both ends is a mesh of the bioinsertion thread 6. It is disposed on one surface of the member 4.
- the tissue graft 2 disclosed in FIG. 8 is connected to the mesh member 4 and the living body insertion thread 6 by a knot 10. It becomes.
- both ends of the mesh member 4 are fixed to the living body insertion thread 6 in a knotted manner, the mesh member 4 can be reliably prevented from being separated from the living body insertion thread 6.
- the tissue giant implant 2 shown in FIG. 9 is bonded to both sides of the mesh member 4 while being mounted on one surface of the thread 6 for inserting a living body. It becomes. That is, the living body insertion seal 6 is not coupled to the mesh member 4 while passing through the pores h of the mesh member in an up-and-down alternating manner, and may be simply connected to each other by only an adhesive.
- Such a tissue-coated implant (2) is easy to manufacture because the seal 6 for insertion of the living body is not coupled in a zigzag form at both ends of the mesh member (4).
- the tissue elevation implant 2 disclosed in FIGS. 10 and 11 illustrates that the mesh member 4 is cylindrical.
- the cylindrical mesh member 4 is tied and installed so that the knot 10 is formed at the rear of the removal part (a) formed of 15 mm to 20 mm from the tip of the insertion direction of the bio-insertable seal 6 on which the protrusion 8 is formed. do. That is, the removal part (a) is left on one side of the living body insertion thread (6) and coupled to the living body insertion thread (6) to facilitate the pulling adjustment of the cylindrical mesh member (4).
- the cylindrical mesh member 4 has a length of 15 mm to 60 mm, an outer diameter of 3.0 mm to 4.5 mm, and a size of the void h of 1.0 mm to 2.0 mm so as to easily exhibit adhesion and supporting force of the tissue.
- tissue graft 2 shown in Figure 12 has a shape almost similar to the tissue grafts shown in Figures 10 and 11, the living body insertion thread 6 combined with the mesh member 4 No projections are formed on the surface of the.
- the tissue graft 2 shown in FIGS. 13 and 14 includes a living body mesh member and a living body insert that are separately manufactured, such as the tissue grafts shown in FIGS. 1 to 4, with an adhesive or a knot. It is characterized in that the mesh member 4 and the living body inserting seal 6 are integrally formed with each other to form a body rather than being fabricated by bonding. At this time, the mesh member 4 and the thread for inserting the living body 6 are formed in a single body by injection molding. Since the mesh member 4 and the living body inserting thread 6 are formed of the same material as each other, the mesh member 4 and the living body inserting thread 6 are not only difficult to separate from each other, but also extend to the same degree. There is an advantage.
- the tissue graft 2 of the present invention is inserted into the tissue between the skin S and the subcutaneous muscle layer m to lift the tissue as shown in FIG. 15.
- the skin (S) and the subcutaneous muscle tissue (m) grow into the pores (h) of the mesh member (4) over time, and the skin (S) and the subcutaneous muscle tissue (m) grow (tissue). ingrowth fills the mesh member void h and thus adheres to the mesh member 4.
- the insertion member 20 shown in FIG. 16 to facilitate the insertion and operation of the tissue graft 2, is composed of an insertion tube (20h) and the guide needle (22).
- the insertion tube 20h has a length of 140 mm to 250 mm and has an outer diameter of 1.6 mm to 2.8 mm and an inner diameter of 1.3 mm to 2.5 mm so that the tissue graft 2 can be easily inserted.
- the guide needle 22 may have a length of 145 mm to 255 mm and a diameter of 1.2 mm to 2.4 mm so that the insertion tube 20h can be easily inserted into the skin and subcutaneous muscle tissue. It protrudes from the end of the insertion tube so that the insertion tube 20h can be easily inserted between the skin and the muscle layer.
- a handle 22a is formed at the rear end of the guide needle 22.
- the guide needle 22 is removed from the insertion tube 20h, and the thread guide needle 23 as shown in FIG. ) Is inserted into the insertion tube (20h).
- the thread guide needle (23) is to serve to guide the g (g) of the thread for a living body insert through the insertion tube (20h) to penetrate the skin of the predetermined site.
- the mesh member 4 coupled to the thread 6 is firmly adhered to the tissue to be fibrous, thereby spreading wrinkled skin and lifting sagging skin.
- the insertion member 20 is advanced through the incision through the skin (S) and the subcutaneous muscle (m) layer until it penetrates the skin. After removing the guide needle 22 while leaving the insertion tube 20h as it is, as shown in FIG. 19, the guide portion g of the thread for living body insertion is hooked on the thread guide needle 23, and this is inserted into the insertion tube 20h. After passing through, let them break through the skin of the intended area.
- Tissue grafts (2) applied to the skin (S) and subcutaneous muscle (m) layers adhere firmly as the tissue growing over time fills the mesh voids (h).
- the mesh member 4 Since the mesh member 4 is adhered not only to the treatment site but also to the surrounding tissues, the entire treatment area is lifted as the treatment time passes, thereby improving the tissue coarseness effect.
Abstract
Description
Claims (22)
- 처지거나 주름진 피부(S)와 피하 근육(m)층 사이에 삽입시켜 조직을 당기거나 펼 수 있도록 하는 조직거상용 이식물에 있어서,상기 조직거상용 이식물(2)은,상기 피부와 상기 피하 근육 층 사이에 삽입될 수 있으며 당김이 요구되는 부위인 원위부와 당기는 부위인 근위부를 가지는 생체 삽입용 실(6); 및상기 생체 삽입용 실(6)의 원위부 측에 고정결합되어 있으며, 다수의 공극(h)이 마련되고, 상기 공극(h) 내에 생체 조직이 성장되어 채워질 수 있는 메쉬부재(4)를 포함하는 것을 특징으로 하는 조직거상용 이식물.
- 처지거나 주름진 피부(S)와 피하 근육(m)층 사이에 삽입시켜 조직을 당기거나 펼 수 있도록 하는 조직거상용 이식물에 있어서,상기 조직거상용 이식물(2)은,상기 피부와 상기 피하 근육 층 사이에 삽입될 수 있으며 당김이 요구되는 부위인 원위부와 당기는 부위인 근위부를 가지는 생체 삽입용 실(6); 및상기 생체 삽입용 실(6)의 원위부 측에 상기 생체 삽입용 실(6)과 한 몸체로 일체화되어 형성되어 있으며, 다수의 공극(h)이 마련되고, 상기 공극(h) 내에 생체 조직이 성장되어 채워질 수 있는 메쉬부재(4)를 포함하는 것을 특징으로 하는 조직거상용 이식물.
- 제1항 또는 제2항에 있어서,상기 생체 삽입용 실(6)에는 돌기(8)가 형성될 수 있는 것을 특징으로 하는 조직거상용 이식물.
- 제1항 또는 제2항에 있어서,상기 메쉬부재(4)는, 원통형 또는 평면형으로 이루어지는 것을 특징으로 하는 조직거상용 이식물.
- 제1항 또는 제2항에 있어서,상기 생체 삽입용 실(6)은 메쉬부재(4)의 양측으로 일정 길이 연장시키면서 상기 메쉬부재(4)를 관통하는 것을 특징으로 하는 조직거상용 이식물.
- 제1항에 있어서,상기 메쉬부재(4)의 양측 단부가 상기 생체 삽입용 실(6)에 고정결합되는 것을 특징으로 하는 조직거상용 이식물.
- 제 1 항에 있어서,상기 생체 삽입용 실(6)과 메쉬부재(4)는,가열접착하는 방식, 매듭으로 묶는 방식 또는 의료용 접착제로 부착시키는 방식 중 어느 하나의 방식에 의하여 결합되는 것을 특징으로 하는 조직거상용 이식물.
- 제2항에 있어서,상기 생체 삽입용 실(6)과 메쉬부재(4)는,사출성형을 통해 일체화되는 것을 특징으로 하는 조직거상용 이식물.
- 제1항 또는 제2항에 있어서,상기 생체 삽입용 실(6)은,시술의 안정성을 확보하면서 외부에 시술 표시가 나타나지 않도록 하는 굵기인 0.25mm ~ 1.5mm를 가지는 것을 특징으로 하는 조직거상용 이식물.
- 제3항에 있어서,상기 생체 삽입용 실(6)은,상기 돌기(8)들이 일정 방향을 향해 표면에 돌출되는 돌기부(t)와,상기 돌기부(t)와 일체로 연결되며 돌기를 생략하여 근막에 고정할 수 있도록 형성되는 무돌기부(r)를 포함하는 것을 특징으로 하는 조직거상용 이식물.
- 제10항에 있어서,상기 돌기부(t)는,메쉬부재(4)가 결합된 일측에 리프팅 조절시 피부(S)를 관통시켜 당길 수 있고 고정 후 용이하게 제거할 수 있는 길이인 15mm ~ 25mm 내에서 제거부(a)가 형성되는 것을 특징으로 하는 조직거상용 이식물.
- 제 10 항에 있어서,상기 돌기부(t)의 돌기(8)는,각 돌기의 간격을 2 ~ 4mm의 범위로 하고, 절단형 돌기인 경우 절단깊이가 25% 이하 범위로 하며, 절단각도를 10ㅀ 이하 범위로 하는 것을 특징으로 하는 조직거상용 이식물.
- 제 10 항에 있어서,상기 돌기부(t)의 돌기(8)는,지지력을 분산할 수 있도록 생체 삽입용 실(6)의 표면에 나선형태로 배치되어 형성되는 것을 특징으로 하는 조직거상용 이식물.
- 제 1 항에 있어서,상기 메쉬부재(4)는, 편직(knitting)되거나 사출성형(injection molding)으로 형성되는 것을 특징으로 하는 조직거상용 이식물.
- 제14항에 있어서,상기 메쉬부재(4)는, 인장력을 유지하기 위해 열처리 가공되어 형성되는 것을 특징으로 하는 조직거상용 이식물.
- 제11항에 있어서,상기 메쉬부재는,상기 메쉬부재의 당김 조정이 가능하도록 생체 삽입용 실(6)의 제거부(a) 선단으로부터 15mm ~ 25mm 후방에 결합되는 것을 특징으로 하는 조직거상용 이식물.
- 제4항에 있어서,상기 메쉬부재(4)가 원통형인 경우, 조직의 유착과 지지력이 향상되도록 길이가 15mm ~ 60mm이고 외경은 3.0mm ~ 4.5mm이며 메쉬 공극(h)은 크기가 1mm ~ 2mm 인 것을 특징으로 하는 조직거상용 이식물.
- 제4항에 있어서,상기 메쉬부재(4)가 평면형인 경우, 길이가 15mm ~ 60mm이고 폭은 3.0mm ~ 4.5mm이며 메쉬 공극(h)은 크기가 1mm ~ 2 mm인 것을 특징으로 하는 조직거상용 이식물.
- 제 1 항에 있어서,상기 조직거상용 이식물(2)은,인체에 무해하고 시간이 경과함에 따라 생체내 흡수되는 폴리디옥사논(polydioxanone), 폴리락트산(poly-(l-lactic) acid), 폴리글리콜산(polyglycolic acid), 폴리카프로락톤(polycaprolactone) 및 이들의 공중합체인 생체 흡수성 의료용 고분자 재료나 폴리프로필렌(polyprophylene)및 이들의 혼합물로 이루어진 생체 적합성 의료용 고분자 소재로 형성되는 것을 특징으로 하는 조직거상용 이식물.
- 제1항에 있어서,상기 조직거상용 이식물(2)은,일정 넓이의 면 형태로 형성되는 평면형 메쉬부재(4)와, 상기 평면형 메쉬부재(4)의 공극(h)을 생체 삽입용 실(6)로 상부에서 하부로 끼우고 다시 다른 메쉬의 공극(h)을 하부에서 상부로 끼우는 것을 반복하여 생체 삽입용 실(6)을 메쉬부재(4)에 관통시켜 생체 삽입용 실(6)과 메쉬부재(4)를 결합시키는 것을 특징으로 하는 조직거상용 이식물.
- 제1항에 있어서,상기 생체 삽입용 실(6)은,삽입관(20h)에 삽입된 실(6)의 일부가 노출될 수 있도록 길이를 120mm ~ 230mm로 형성하고 삽입관(20h)에 삽입되는 실(6)의 통과를 안내할 수 있도록 실(6)의 일측에 돌기 없이 연장되는 안내부(g)가 형성된 것을 특징으로 하는 조직거상용 이식물.
- 제21항에 있어서,상기 조직거상용 이식물(2)은,길이는 140mm ~ 250mm이고 외경은 1.6mm ~ 2.8mm이며 내경은 1.3mm ~ 2.5mm로 조직에 삽입 가능하도록 형성되는 삽입관(20h)과, 상기 삽입관(20h) 내에서 삽입관(20h)의 삽입을 안내하도록 길이가 145mm ~ 255mm이고 직경이 1.2mm ~ 2.4mm로 형성되는 유도바늘(22)을 구비한 삽입부재(20)와, 일측 또는 타측에 형성된 구멍을 통하여 실(6)의 안내부(g)를 걸고 상기 삽입관(20h)을 통과하는 실 안내바늘(23)을 이용하여 시술되는 것을 특징으로 하는 조직거상용 이식물.
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES12844704.2T ES2652237T3 (es) | 2011-10-31 | 2012-06-05 | Injerto para estiramiento del tejido |
EP12844704.2A EP2774579B1 (en) | 2011-10-31 | 2012-06-05 | Graft for tissue lifting |
AU2012333418A AU2012333418A1 (en) | 2011-10-31 | 2012-06-05 | Graft for tissue lifting |
RU2014114433/14A RU2573804C2 (ru) | 2011-10-31 | 2012-06-05 | Имплантат для подтяжки ткани |
JP2014538689A JP5984949B2 (ja) | 2011-10-31 | 2012-06-05 | 組織挙上用移植物 |
US14/000,775 US11045299B2 (en) | 2011-10-31 | 2012-06-05 | Implant for tissue lifting |
CN201280016917.XA CN103458827B (zh) | 2011-10-31 | 2012-06-05 | 组织提拉用移植物 |
BR112014010020A BR112014010020A2 (pt) | 2011-10-31 | 2012-06-05 | enxerto para elevação de tecido que é inserido entre a pele flácida ou enrugada e o músculo subcutâneo para permitir o puxamento e/ou o alisamento de tecido |
PL12844704T PL2774579T3 (pl) | 2011-10-31 | 2012-06-05 | Przeszczep do podnoszenia tkanek |
CA2853921A CA2853921A1 (en) | 2011-10-31 | 2012-06-05 | Graft for tissue lifting |
IN832/KOLNP/2014A IN2014KN00832A (en) | 2011-10-31 | 2014-04-14 | Graft for tissue lifting |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110112135A KR101155817B1 (ko) | 2011-10-31 | 2011-10-31 | 조직거상용 이식물 |
KR10-2011-0112135 | 2011-10-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013065923A1 true WO2013065923A1 (ko) | 2013-05-10 |
Family
ID=46607486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2012/004421 WO2013065923A1 (ko) | 2011-10-31 | 2012-06-05 | 조직거상용 이식물 |
Country Status (13)
Country | Link |
---|---|
US (1) | US11045299B2 (ko) |
EP (1) | EP2774579B1 (ko) |
JP (1) | JP5984949B2 (ko) |
KR (1) | KR101155817B1 (ko) |
CN (1) | CN103458827B (ko) |
AU (1) | AU2012333418A1 (ko) |
BR (1) | BR112014010020A2 (ko) |
CA (1) | CA2853921A1 (ko) |
ES (1) | ES2652237T3 (ko) |
IN (1) | IN2014KN00832A (ko) |
PL (1) | PL2774579T3 (ko) |
RU (1) | RU2573804C2 (ko) |
WO (1) | WO2013065923A1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017217742A1 (ko) * | 2016-06-16 | 2017-12-21 | 김종우 | 역u자형 조직 현수 고정장치 및 조직 현수 고정장치 |
KR101825736B1 (ko) * | 2017-06-15 | 2018-02-05 | 심재완 | 조직 수복용 메쉬 어셈블리 |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2009288118B2 (en) | 2008-09-02 | 2014-12-11 | Allergan, Inc. | Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof |
KR101132841B1 (ko) | 2011-03-07 | 2012-04-02 | 김영재 | 봉합사 |
KR101185583B1 (ko) | 2011-12-27 | 2012-09-24 | 김영재 | 매듭짓는 작업이 필요 없는 봉합사 및 이를 포함하는 키트 |
CN107811665B (zh) * | 2012-02-23 | 2020-09-04 | 高级缝合有限公司 | 改进的缝合线 |
US10278694B2 (en) | 2012-02-23 | 2019-05-07 | Northwestern University | Indirect attachment of a needle to a mesh suture |
KR101432268B1 (ko) | 2012-09-03 | 2014-08-21 | 구태훈 | 연조직 복원술용 메쉬, 이를 연조직에 삽입하기 위한 공간 형성 기구와, 메쉬 삽입 기구 및, 공간 형성 기구와 메쉬 삽입기구를 포함하는 수술기구 세트 |
US10010317B2 (en) | 2012-12-05 | 2018-07-03 | Young Jae Kim | Method of improving elasticity of tissue of living body |
US10178990B2 (en) | 2012-12-05 | 2019-01-15 | Y. Jacobs Medical Inc. | Apparatus for inserting surgical thread, and surgical procedure kit for inserting surgical thread comprising same |
KR101401840B1 (ko) | 2013-01-14 | 2014-05-29 | 김태원 | 거상 수술용 메쉬 |
US20140350518A1 (en) | 2013-05-23 | 2014-11-27 | Allergan, Inc. | Syringe extrusion accessory |
CN104510142A (zh) * | 2013-09-29 | 2015-04-15 | 陈青山 | 基于体外的无创消除眼周动态皱纹的美容方法及其装置 |
US10226320B2 (en) | 2013-12-06 | 2019-03-12 | Y.Jacobs Medical Inc. | Apparatus for inserting medical tube and surgical procedure kit for inserting medical tube, having same |
KR101403979B1 (ko) * | 2013-12-09 | 2014-06-10 | 윤인모 | 성형수술용 리프트 재료 |
US9968745B2 (en) | 2014-01-27 | 2018-05-15 | Allergan Holdings France S.A.S. | Substance delivery device |
US10029048B2 (en) | 2014-05-13 | 2018-07-24 | Allergan, Inc. | High force injection devices |
KR101500275B1 (ko) * | 2014-06-24 | 2015-03-06 | 민웅재 | 성형시술용 실 |
CN104116529B (zh) * | 2014-08-11 | 2016-08-24 | 宁波市鄞州云帆工程咨询有限公司 | 防滑齿适时伸缩式除皱提拉器 |
US10226585B2 (en) | 2014-10-01 | 2019-03-12 | Allergan, Inc. | Devices for injection and dosing |
ES2570077B1 (es) * | 2014-10-13 | 2017-03-03 | Jack KANOUZI BASCHOUR | Anillo protésico implantacional para la corrección y prevención de la asimetría areolar mamaria |
KR101684631B1 (ko) * | 2014-11-13 | 2016-12-07 | 김근식 | 봉합사와 천연 고분자를 이용한 리프팅 부재 |
KR101635580B1 (ko) * | 2014-12-03 | 2016-07-20 | 김근식 | 메쉬형 리프팅 부재 |
KR101635581B1 (ko) * | 2015-01-07 | 2016-07-04 | 김근식 | 메쉬형 리프팅 부재 |
KR101534820B1 (ko) * | 2015-01-23 | 2015-07-08 | 심길섭 | 전립선 비대증 치료용 임플란트 |
KR101534821B1 (ko) * | 2015-01-23 | 2015-07-08 | 심길섭 | 성형수술용 주름제거 메쉬 어셈블리 |
KR101534814B1 (ko) * | 2015-03-05 | 2015-07-08 | 심길섭 | 주름제거 메쉬 어셈블리 |
WO2016145230A1 (en) | 2015-03-10 | 2016-09-15 | Unger Jacob G | Multiple needle injector |
KR101620793B1 (ko) | 2015-09-16 | 2016-05-12 | 심길섭 | 피부 박리용 실 |
KR101773774B1 (ko) * | 2015-12-24 | 2017-09-01 | 유성식 | 피부 주름 제거를 위한 성형용 실 |
US10596321B2 (en) | 2016-04-08 | 2020-03-24 | Allergan, Inc. | Aspiration and injection device |
KR101738666B1 (ko) | 2016-07-19 | 2017-05-23 | 김종우 | 역u자형 조직 현수 고정장치 및 조직 현수 고정장치 |
KR101770758B1 (ko) * | 2016-06-16 | 2017-08-24 | 김종우 | 역u자형 조직 현수 고정장치 및 조직 현수 고정장치 |
WO2018009031A1 (ko) * | 2016-07-08 | 2018-01-11 | 김정권 | 리프팅용 봉합사 및 그 제조방법 |
KR101729187B1 (ko) | 2016-09-06 | 2017-04-21 | 김동진 | 성형 수술용 그물 조립체 |
WO2018057594A1 (en) * | 2016-09-20 | 2018-03-29 | Surgical Innovation Associates, Inc. | Apparatus and method for lifting or restraining a body part |
KR101682419B1 (ko) * | 2016-10-06 | 2016-12-05 | 이준성 | 분기점이 마련된 리프팅용 수술도구 |
WO2018127907A1 (en) * | 2017-01-03 | 2018-07-12 | Talisman Ran | Surgical thread for plastic surgery |
US10265151B2 (en) | 2017-01-24 | 2019-04-23 | Allergan Industrie Sas | Thread insertion devices |
US10820900B2 (en) | 2017-01-24 | 2020-11-03 | Allergan Industrie Sas | Thread insertion devices |
US10258447B2 (en) | 2017-01-24 | 2019-04-16 | Allergan Industrie Sas | Thread insertion devices |
US10595977B2 (en) | 2017-01-24 | 2020-03-24 | Allergan Industrie, Sas | Thread insertion devices |
US10709444B2 (en) | 2017-01-24 | 2020-07-14 | Allergan Industrie Sas | Thread insertion devices |
USD867582S1 (en) | 2017-03-24 | 2019-11-19 | Allergan, Inc. | Syringe device |
KR101905162B1 (ko) * | 2017-06-05 | 2018-10-08 | 주식회사 동방메디컬 | 리프팅 부재 |
KR101917219B1 (ko) * | 2017-09-29 | 2018-11-09 | 주식회사 파인비엠 | 관형 멀티 봉합사 결합 키트 |
CN108588612B (zh) * | 2018-04-28 | 2019-09-20 | 育材堂(苏州)材料科技有限公司 | 热冲压成形构件、热冲压成形用预涂镀钢板及热冲压成形工艺 |
KR102139509B1 (ko) * | 2018-08-24 | 2020-07-29 | 주식회사 네오닥터 | 실 삽입기 |
KR101974330B1 (ko) * | 2019-03-22 | 2019-09-02 | 정홍우 | 시술용 매선 |
KR102234637B1 (ko) * | 2020-02-26 | 2021-04-01 | 윤영묵 | 피부 주름 제거 시술유닛 |
CN116437872A (zh) * | 2020-06-10 | 2023-07-14 | 里兰斯坦福初级大学理事会 | 用于改变鼻组织的形状的系统和方法 |
KR102430704B1 (ko) * | 2020-10-05 | 2022-08-09 | 김재훈 | 망체를 포함한 의료용 실의 제조 방법 |
US20220202551A1 (en) * | 2020-12-31 | 2022-06-30 | Mickey M. Karram | Device for treating urinary stress incontinence |
CN112914788A (zh) * | 2021-03-22 | 2021-06-08 | 艾斯美(美国)国际有限公司 | 一种用于皮肤组织提拉的装置和方法 |
KR102411628B1 (ko) * | 2021-11-09 | 2022-06-22 | 오해석 | 코 성형용 리프팅 실 |
US11911255B1 (en) | 2021-07-12 | 2024-02-27 | Mariano Busso | Systems and methods for superficial facial fat pad repositioning |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005096956A1 (en) | 2004-04-07 | 2005-10-20 | Tze Liang Woffles Wu | Surgical thread |
KR20070048178A (ko) | 2004-07-28 | 2007-05-08 | 에디컨인코포레이티드 | 최소 침습성 의료용 임플란트 및 삽입 장치와 그 사용 방법 |
KR100724706B1 (ko) | 2006-03-29 | 2007-06-07 | 한스바이오메드 주식회사 | 미세기공을 갖는 수술용 실 |
KR100745571B1 (ko) * | 2006-06-15 | 2007-08-03 | 이정일 | 성형수술용 선형인장재 |
KR20070093256A (ko) | 2006-03-13 | 2007-09-18 | 양현진 | 생체 연부조직 연장술을 위한 항 압박 다중 섬유유착봉합법에 이용하는 생체 삽입용 실과 그것을 생체에삽입하기 위한 도구 |
JP2007330593A (ja) * | 2006-06-16 | 2007-12-27 | Katsuya Takasu | 形成外科用手術糸及び皮膚の引張付与方法 |
KR200442490Y1 (ko) | 2007-03-21 | 2008-11-13 | 황영옥 | 얼굴 주름 제거용 실 삽입기구 |
KR100886757B1 (ko) | 2008-06-04 | 2009-03-04 | 문정일 | 안면 거상 장치 |
KR20090036748A (ko) * | 2007-05-01 | 2009-04-15 | 박재영 | 주름 제거용 리프팅 도구 |
KR20100030650A (ko) * | 2007-06-12 | 2010-03-18 | 프로메돈 도 브라질 프로두토스 메디코 하스피탈라레스 엘티디에이. | 요실금 및 변실금 치료를 위한 마이크로 슬링 및 이식 장치 |
KR20100058650A (ko) | 2007-09-26 | 2010-06-03 | 에디컨인코포레이티드 | 자체 고정식 조직 거상 장치 및 상기 장치의 제조 방법 |
KR20100134941A (ko) | 2009-06-16 | 2010-12-24 | 임기표 | 시간차 안면거상술용 거상장치 |
KR101044731B1 (ko) * | 2010-12-02 | 2011-06-28 | 구태훈 | 연조직 복원술용 메쉬 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6475139B1 (en) * | 1999-06-09 | 2002-11-05 | Ethicon, Inc. | Visually-directed surgical instrument and method for treating female urinary incontinence |
US20110168192A9 (en) * | 2000-12-20 | 2011-07-14 | Eduardo Fierro | Adjustable autofixing sling for treatment of urinary incontinence |
US6595911B2 (en) * | 2001-04-03 | 2003-07-22 | Lovuolo Michael | Method and device for anchor implantation and support of bodily structures |
US8236027B2 (en) * | 2004-04-07 | 2012-08-07 | Tze Liang Woffles Wu | Surgical thread |
WO2005096955A1 (en) * | 2004-04-07 | 2005-10-20 | Tze Liang Woffles Wu | Surgical thread |
US7582105B2 (en) * | 2004-06-30 | 2009-09-01 | Silhouette Lift Societad Limitada | Suture for wound closure, tissue approximation, tissue support, suspension and/or fixation |
US20060058892A1 (en) * | 2004-09-16 | 2006-03-16 | Lesh Michael D | Valved tissue augmentation implant |
WO2006034077A1 (en) * | 2004-09-16 | 2006-03-30 | Juva Medical, Inc. | Tissue augmentation device |
US20070156175A1 (en) * | 2005-12-29 | 2007-07-05 | Weadock Kevin S | Device for attaching, relocating and reinforcing tissue and methods of using same |
US20070173887A1 (en) * | 2006-01-24 | 2007-07-26 | Sasaki Gordon H | Suture and method using a suture |
US8480557B2 (en) | 2006-07-27 | 2013-07-09 | Refine, Llc | Nonaugmentive mastopexy |
US20090248071A1 (en) * | 2008-03-07 | 2009-10-01 | Alure Medical , Inc. | Minimally invasive tissue support |
EP2076214A2 (en) | 2006-10-03 | 2009-07-08 | Alure Medical, Inc. | Minimally invasive tissue support |
US20090018655A1 (en) * | 2007-07-13 | 2009-01-15 | John Brunelle | Composite Implant for Surgical Repair |
CN101861129A (zh) | 2007-11-15 | 2010-10-13 | 马里昂·德沃纳 | 用于塑造或提拉人体中正常或扩张组织的装置 |
CN201098221Y (zh) * | 2007-11-15 | 2008-08-13 | 浙江普洛医药科技有限公司 | 一种整形手术用的整形带 |
US9282958B2 (en) * | 2007-12-28 | 2016-03-15 | Boston Scientific Scimed, Inc. | Devices and method for treating pelvic dysfunctions |
US20100025643A1 (en) | 2008-07-31 | 2010-02-04 | Clariant International Ltd. | Flame-retardant mixture for thermoplastic polymers, and flame-retardant polymers |
KR101739304B1 (ko) * | 2008-08-25 | 2017-05-24 | 에이엠에스 리서치 코포레이션 | 최소 침수성 임플란트 조합 |
WO2010051506A1 (en) * | 2008-10-31 | 2010-05-06 | Alure Medical, Inc. | Minimally invasive tissue support system and method with a superior tissue support and an inferior anchor |
ES2731162T3 (es) | 2009-07-22 | 2019-11-14 | Bosch Gmbh Robert | Sistema de conferencia, método para operar la unidad de delegado y programa informático |
US9011487B2 (en) * | 2009-08-27 | 2015-04-21 | Ethicon, Inc. | Barbed sutures having pledget stoppers and methods therefor |
GB2474866B8 (en) * | 2009-10-29 | 2013-04-10 | Xiros Ltd | Knot slip resistant woven cord |
US9060837B2 (en) * | 2009-11-23 | 2015-06-23 | Ams Research Corporation | Patterned sling implant and method |
US9398943B2 (en) * | 2009-11-30 | 2016-07-26 | Covidien Lp | Ventral hernia repair with barbed suture |
WO2011091483A1 (en) * | 2010-01-26 | 2011-08-04 | Dokter Philippe Ehlinger, Besloten Vennootschap Met Beperkte Aansprakelijheid | Surgical thread and surgical device for lifting and suspension of soft tissues. |
US8550979B2 (en) * | 2010-06-15 | 2013-10-08 | Coloplast A/S | Method of treating incontinence |
RU106528U1 (ru) * | 2010-12-29 | 2011-07-20 | Закрытое акционерное общество "Биннофарм" | Клеточный имплантат для восстановления дефектов кожного покрова |
US10188493B2 (en) * | 2011-05-13 | 2019-01-29 | Atex Technologies, Inc. | Surgical mesh with dimensionally stabilized pore |
KR101182337B1 (ko) * | 2012-02-14 | 2012-09-20 | (주)프레스티지 메디케어 | 의료용 메쉬 구조 |
-
2011
- 2011-10-31 KR KR1020110112135A patent/KR101155817B1/ko active IP Right Review Request
-
2012
- 2012-06-05 BR BR112014010020A patent/BR112014010020A2/pt not_active Application Discontinuation
- 2012-06-05 RU RU2014114433/14A patent/RU2573804C2/ru active
- 2012-06-05 EP EP12844704.2A patent/EP2774579B1/en active Active
- 2012-06-05 WO PCT/KR2012/004421 patent/WO2013065923A1/ko active Application Filing
- 2012-06-05 JP JP2014538689A patent/JP5984949B2/ja active Active
- 2012-06-05 AU AU2012333418A patent/AU2012333418A1/en not_active Abandoned
- 2012-06-05 CN CN201280016917.XA patent/CN103458827B/zh active Active
- 2012-06-05 PL PL12844704T patent/PL2774579T3/pl unknown
- 2012-06-05 ES ES12844704.2T patent/ES2652237T3/es active Active
- 2012-06-05 CA CA2853921A patent/CA2853921A1/en not_active Abandoned
- 2012-06-05 US US14/000,775 patent/US11045299B2/en active Active
-
2014
- 2014-04-14 IN IN832/KOLNP/2014A patent/IN2014KN00832A/en unknown
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005096956A1 (en) | 2004-04-07 | 2005-10-20 | Tze Liang Woffles Wu | Surgical thread |
KR20070048178A (ko) | 2004-07-28 | 2007-05-08 | 에디컨인코포레이티드 | 최소 침습성 의료용 임플란트 및 삽입 장치와 그 사용 방법 |
KR20070093256A (ko) | 2006-03-13 | 2007-09-18 | 양현진 | 생체 연부조직 연장술을 위한 항 압박 다중 섬유유착봉합법에 이용하는 생체 삽입용 실과 그것을 생체에삽입하기 위한 도구 |
KR100724706B1 (ko) | 2006-03-29 | 2007-06-07 | 한스바이오메드 주식회사 | 미세기공을 갖는 수술용 실 |
KR100745571B1 (ko) * | 2006-06-15 | 2007-08-03 | 이정일 | 성형수술용 선형인장재 |
JP2007330593A (ja) * | 2006-06-16 | 2007-12-27 | Katsuya Takasu | 形成外科用手術糸及び皮膚の引張付与方法 |
KR200442490Y1 (ko) | 2007-03-21 | 2008-11-13 | 황영옥 | 얼굴 주름 제거용 실 삽입기구 |
KR20090036748A (ko) * | 2007-05-01 | 2009-04-15 | 박재영 | 주름 제거용 리프팅 도구 |
KR20100030650A (ko) * | 2007-06-12 | 2010-03-18 | 프로메돈 도 브라질 프로두토스 메디코 하스피탈라레스 엘티디에이. | 요실금 및 변실금 치료를 위한 마이크로 슬링 및 이식 장치 |
KR20100058650A (ko) | 2007-09-26 | 2010-06-03 | 에디컨인코포레이티드 | 자체 고정식 조직 거상 장치 및 상기 장치의 제조 방법 |
KR100886757B1 (ko) | 2008-06-04 | 2009-03-04 | 문정일 | 안면 거상 장치 |
KR20100134941A (ko) | 2009-06-16 | 2010-12-24 | 임기표 | 시간차 안면거상술용 거상장치 |
KR101044731B1 (ko) * | 2010-12-02 | 2011-06-28 | 구태훈 | 연조직 복원술용 메쉬 |
Non-Patent Citations (1)
Title |
---|
See also references of EP2774579A4 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017217742A1 (ko) * | 2016-06-16 | 2017-12-21 | 김종우 | 역u자형 조직 현수 고정장치 및 조직 현수 고정장치 |
KR101825736B1 (ko) * | 2017-06-15 | 2018-02-05 | 심재완 | 조직 수복용 메쉬 어셈블리 |
Also Published As
Publication number | Publication date |
---|---|
US20140228971A1 (en) | 2014-08-14 |
JP5984949B2 (ja) | 2016-09-06 |
KR101155817B1 (ko) | 2012-06-12 |
EP2774579A1 (en) | 2014-09-10 |
PL2774579T3 (pl) | 2018-02-28 |
CA2853921A1 (en) | 2013-05-10 |
KR101155817B9 (ko) | 2023-12-07 |
EP2774579B1 (en) | 2017-09-13 |
BR112014010020A2 (pt) | 2017-04-25 |
RU2573804C2 (ru) | 2016-01-27 |
EP2774579A4 (en) | 2015-03-25 |
ES2652237T3 (es) | 2018-02-01 |
IN2014KN00832A (en) | 2015-10-02 |
CN103458827A (zh) | 2013-12-18 |
CN103458827B (zh) | 2018-01-30 |
JP2015501186A (ja) | 2015-01-15 |
AU2012333418A1 (en) | 2014-05-29 |
US11045299B2 (en) | 2021-06-29 |
RU2014114433A (ru) | 2015-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013065923A1 (ko) | 조직거상용 이식물 | |
US10682213B2 (en) | Surgical implant consisting of non-absorbable material | |
RU2472531C2 (ru) | Двухслойный хирургический протез для замещения мягких тканей | |
JP4903141B2 (ja) | 低侵襲性医療インプラントならびにその挿入器具および使用方法 | |
JP2001511685A (ja) | 低侵襲骨盤手術で使用するための安定化スリング | |
JP2008536594A (ja) | 支持インプラントのための補綴編物 | |
KR100982613B1 (ko) | 생분해부를 가진 요실금 치료용 메쉬 및 그 직조방법 | |
CN210447279U (zh) | 一种应用于腹股沟疝的轻质疝修补装置 | |
CN115381590A (zh) | 一种男性尿失禁补片及其使用方法 | |
ITMI970166A1 (it) | Placca chirurgica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12844704 Country of ref document: EP Kind code of ref document: A1 |
|
REEP | Request for entry into the european phase |
Ref document number: 2012844704 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14000775 Country of ref document: US Ref document number: 2012844704 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2014538689 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2853921 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2012333418 Country of ref document: AU Date of ref document: 20120605 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2014114433 Country of ref document: RU Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112014010020 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112014010020 Country of ref document: BR Kind code of ref document: A2 Effective date: 20140425 |